Vort John Vander, Director at ARATANA THERAPEUTICS, INC. (PETX), sold 6,137 shares at $20.01 ($123K) on 2015-03-06, disclosed to the SEC on 2015-03-06.
Scheduled sale ($123k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PLIN | BUY | 2009-01-15 | $49K | — | Filing → |